Products

What will AGI do for Benoxaprofen?

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H12ClNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 17SZX404IM, chemically known as 5-benzoxazoleacetic acid, 2-(4-chlorophenyl)-alpha-methyl, (+-)- but generally known as benoxaprofen, which bears US NIH Compound Identifier 39941. Benoxaprofen most often comes in base and glucuronide forms. European Medicines Agency schedules Benoxaprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05725MIG. The term BENOXAPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules benoxaprofen in its Anatomical Therapeutic Chemical (ATC) Classification. BENOXAPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benoxaprofen under HS 29349990 and SITC 51579. As of Q4 2014, BENOXAPROFEN remains the US FDA Preferred Term for this commodity. Benoxaprofen bears US NLM identifiers UMLS ID C0053111 and NCI Concept Code C76796. SMILES: CLC1CCC(C2OC3C(N2)CC(C(C)C(=O)O)CC3)CC1.